US9561245B2

Combination treatments for melanoma

University of Texas Southwestern

Abstract

The present invention relates to combination therapies for melanoma, and in particular, metastatic melanoma. Drugs for use in such therapies in include BRAF inhibitors such as PLX 4720 and PLX 4734 in combination with RO 31-8220, bafetinib or cardiac glycosides.

University: University of Texas Southwestern
Assignee: The Board Of Regents Of The University Of Texas System
Inventor: Sean Morrison
Priority date: September 06, 2012
Filing date: September 05, 2013
Grant date: February 07, 2017
Publication date: February 07, 2017
Language: en
PDF source: https://patentimages.storage.googleapis.com/20/c4/0f/dfbedda01717eb/US9561245.pdf
Metadata fetched: August 28, 2026 19:17